Rahul Gosain: US FDA approval of Durvalumab for resectable NSCLC with Mara Antonoff and Sandip Patel
Rahul Gosain shared a post on LinkedIn:
”Lung Cancer: We speak about the US FDA approval of Durvalumab based off AEGEAN (and options in perioperative/postoperative) for resectable Non-Small Cell Lung Cancer with Mara Antonoff and Sandip Patel.
Full Discussion:
Drs. Rohit Gosain and Rahul Gosain (aka Oncology Brothers), are medical oncologists/hematologists. Through their social media platforms like X/Twitter, they actively engage with their audience. With their own YouTube channel and podcast, they provide accessible resources for cancer patients and their families. Additionally, their participation in live conferences ensures that cancer patients receive the best care closer to home, reflecting their commitment to advancing oncology and improving patient outcomes through education and outreach.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023